Literature DB >> 7226227

Vitellogenin gene expression in male Xenopus hepatocytes during primary and secondary stimulation with estrogen in cell cultures.

P F Searle, J R Tata.   

Abstract

Primary cultures of male Xenopus liver parenchymal cells that retained their competence to respond to estrogen were used to study the hormone-induced activation of the vitellogenin gene in vitro. The accumulation of vitellogenin mRNA in these cells was monitored by a quantitative diazotized paper disc hybridization procedure with a sensitivity of at least 6 pg of sequences complementary to the probe in total RNA samples of 10 micrograms. A short-term time-course analysis showed that vitellogenin mRNA was detectable within 3 hr of exposure to estrogen during primary stimulation, and that the maximum rate of accumulation was reached at 5--6 hr. A long-term time-course analysis of the accumulation of vitellogenin mRNA showed that it is possible to obtain a primary response, a hormone withdrawal effect and an enhanced secondary response in the same batch of cells in a manner analogous to that observed in vivo. Measurement of hormone concentration dependence showed a response at 10(-9) M estradiol, which continued to increase up to at least 10(-6) M estradiol. This requirement for large doses of estradiol for maximal response can be explained by the rapid metabolism of estradiol by the cultured cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226227     DOI: 10.1016/0092-8674(81)90437-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  13 in total

1.  Chromosomal organization of Xenopus laevis oocyte and somatic 5S rRNA genes in vivo.

Authors:  C C Chipev; A P Wolffe
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

2.  Secretory pathway of vitellogenesis in the liver of the cockerel as revealed by immuno-gold and computer-assisted digitization techniques.

Authors:  K Kami; P J Stoward
Journal:  Histochem J       Date:  1991-06

3.  Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding sites and the rate of avian vitellogenin mRNA synthesis.

Authors:  H P Saluz; J Jiricny; J P Jost
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  A novel nuclear transcription system which responds correctly to cloned estrogen receptor.

Authors:  A Thorburn; J Knowland
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

5.  Simultaneous analysis of conformation and transcription of A and B groups of vitellogenin genes in male and female Xenopus during primary and secondary activation by estrogen.

Authors:  J L Williams; J R Tata
Journal:  Nucleic Acids Res       Date:  1983-02-25       Impact factor: 16.971

6.  The LSP1-alpha gene is not dosage compensated in the Drosophila melanogaster species subgroup.

Authors:  H W Brock; D B Roberts
Journal:  Biochem Genet       Date:  1982-04       Impact factor: 1.890

7.  Activation of vitellogenin gene transcription is a direct response to estrogen in Xenopus laevis liver.

Authors:  M A Hayward; M L Brock; D J Shapiro
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

8.  Differential sensitization to deoxyribonuclease I of Xenopus vitellogenin and albumin genes during primary and secondary induction of vitellogenesis by oestradiol.

Authors:  G J Dimitriadis; J R Tata
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

9.  Construction and partial characterization of a recombinant DNA probe for locust vitellogenin messenger RNA.

Authors:  T C James; U M Bond; C A Maack; S W Applebaum; J R Tata
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

10.  In vitro secondary activation (memory effect) of avian vitellogenin II gene in isolated liver nuclei.

Authors:  J P Jost; B Moncharmont; J Jiricny; H Saluz; T Hertner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.